Market revenue in 2022 | USD 257.2 million |
Market revenue in 2030 | USD 523.7 million |
Growth rate | 9.3% (CAGR from 2022 to 2030) |
Largest segment | Dermal fillers |
Fastest growing segment | Osteoarthritis |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Dermal fillers was the largest segment with a revenue share of 46.66% in 2022. Horizon Databook has segmented the India hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
The Indian government is taking active steps for decreasing the prevalence of ophthalmic diseases and osteoarthritis. The National Programme for Control of Blindness and Visual Impairment (NPCBVI), a 100% central government-sponsored scheme, was launched by the government to reduce the prevalence of blindness to 0.3% by 2020.
According to Central Bureau of Health Intelligence, a total of 6,690,823 cataract surgeries were performed in India during 2018–2019. High prevalence of diabetes and large number of cataract patients are among factors expected to increase the demand for hyaluronic acid-based eye drops and ophthalmic viscoelastic devices.
According to National Health Portal, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Moreover, nearly 45% of women aged 65 and above have symptoms of osteoarthritis, while 70% of women aged 65 and above exhibit radiological evidence of osteoarthritis.
Horizon Databook provides a detailed overview of country-level data and insights on the India hyaluronic acid market , including forecasts for subscribers. This country databook contains high-level insights into India hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account